U9W-31738-20344
4 vaccinations
2 coded responses
49 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 212 / MD
- Registered
- 2021-03-09
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-04
Dose 1 — Pfizer-BioNTech
-
2021-03-09
Registered in v-safe
- 2021-03-09
- 2021-03-10
- 2021-03-13
- 2021-03-18
- 2021-03-25
-
2021-03-26
Dose 2 — Pfizer-BioNTech
-
2021-03-26
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-27
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · HeadacheAdult check-in
-
2021-03-29
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Swelling · Fatigue or tirednessAdult check-in
- 2021-03-30
- 2021-04-01
- 2021-04-02
- 2021-04-09
- 2021-04-16
- 2021-04-23
- 2021-04-30
- 2021-05-07
- 2021-06-25
- 2021-09-24
-
2021-10-29
Dose 3 — Pfizer-BioNTech
- 2021-10-29
-
2021-10-30
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Fatigue or tirednessAdult check-in
-
2021-10-31
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-11-01
Survey response — days 1–6 daily, dose 3MedDRA: Dizziness — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: DizzinessMedDRA releases: 2024-11 · check-in free text available
- 2021-11-02
- 2021-11-03
- 2021-11-04
- 2021-11-05
- 2021-11-12
- 2021-11-19
- 2021-11-26
- 2021-12-03
- 2021-12-10
- 2022-01-28
-
2022-04-29
Survey response — 6 months, dose 3MedDRA: Pregnancy — Feeling: Fair · Be unable to do your normal daily activitiesFree text: become pregnantMedDRA releases: 2024-11 · check-in free text available
-
2022-09-21
Dose 4 — Pfizer-BioNTech
- 2022-09-21
-
2022-09-22
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-09-23
- 2022-09-24
- 2022-09-25
- 2022-09-26
- 2022-09-27
- 2022-09-28
- 2022-10-05
- 2022-10-12
- 2022-10-19
- 2022-10-26
- 2022-11-02
- 2022-12-21
- 2023-03-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-04 | Pfizer-BioNTech | |
| 2 | 2021-03-26 | Pfizer-BioNTech | |
| 3 | 2021-10-29 | Pfizer-BioNTech | No |
| 4 | 2022-09-21 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Dizziness
Release 11 — 6 months, dose 3
Symptoms: become pregnant
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pregnancy | · | · | ✓ |
| SRO | Dizziness | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release